{"id":10163,"date":"2020-12-02T22:08:21","date_gmt":"2020-12-02T13:08:21","guid":{"rendered":"http:\/\/cell.brc.riken.jp\/en\/?page_id=10163"},"modified":"2025-08-25T09:31:31","modified_gmt":"2025-08-25T00:31:31","slug":"diseaselist_8","status":"publish","type":"page","link":"http:\/\/cell.brc.riken.jp\/en\/hps\/patient_specific_ips\/diseaselist_8","title":{"rendered":"Otorhinolaryngologic diseases, Diseases due to chromosomal aberrations and gene mutations"},"content":{"rendered":"

\uff0a When you want to use some Disease-specific iPS cells, please e-mail to the following address.
\n\uff0a In relation to the information that are not described below, please e-mail to the following address.<\/p>\n

Contact us :\u00a0cellips.brc\"\"riken.jp<\/a><\/p>\n

Blue letter cells are available. You obtain the information by clicking the blue letter.
\n*iPS cells created using the Sendai virus vector are now available<\/a><\/p>\n

*Terms:
\nIn relation to all iPS cell lines, approval of institutional review board and\/or institutional ethical committee regarding the research using iPS cells is necessary.
\nIn relation to all iPS cell lines, commercial use is prohibited.
\nIn relation to the cell lines marked with \u25ce, (1) the recipient does not need to obtain an approval from the depositor, (2) there is no need of collaboration with the depositor, and (3) for-profit entities can also utilize.<\/p>\n

Update : 2020.11.27<\/p>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
Name of diseases<\/th>\nPatient No.<\/th>\n*Terms<\/th>\nApproval Form<\/th>\nHPS<\/th>\n<\/th>\n<\/th>\n<\/th>\n<\/th>\n<\/th>\n<\/th>\n<\/th>\n<\/th>\nReferences<\/th>\n<\/tr>\n
Otorhinolaryngologic diseases<\/span><\/strong><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
1. Branchio-oto-renal syndrome<\/strong><\/span><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Branchio-oto-renal syndrome<\/td>\n1<\/td>\n<\/td>\n<\/td>\nHPS3981<\/td>\nHPS3982<\/td>\nHPS3983<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Digestive system diseases<\/span><\/strong><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
1. Primary biliary cirrhosis (PBC)<\/strong><\/span><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Primary biliary cirrhosis (PBC)<\/td>\n1<\/td>\n\u25ce<\/td>\nUnnecessary<\/td>\nHPS1174<\/td>\nHPS1175<\/td>\nHPS1176<\/td>\nHPS1177<\/td>\nHPS1178<\/td>\nHPS1179<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
2<\/td>\n\u25ce<\/td>\nUnnecessary<\/td>\nHPS1234<\/td>\nHPS1235<\/td>\nHPS1236<\/td>\nHPS1237<\/td>\nHPS1238<\/td>\nHPS1239<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
3<\/td>\n\u25ce<\/td>\nUnnecessary<\/td>\nHPS1246<\/td>\nHPS1247<\/td>\nHPS1248<\/td>\nHPS1249<\/td>\nHPS1250<\/td>\nHPS1251<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
4<\/td>\n\u25ce<\/td>\nUnnecessary<\/td>\nHPS1276<\/td>\nHPS1277<\/td>\nHPS1278<\/td>\nHPS1279<\/td>\nHPS1280<\/td>\nHPS1281<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
<\/a>5<\/td>\n\u25ce<\/td>\nUnnecessary<\/td>\nHPS1490<\/td>\nHPS1491<\/td>\nHPS1492<\/td>\nHPS1493<\/td>\nHPS1494<\/td>\nHPS1495<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
2. Primary sclerosing cholangitis (PSC)<\/strong><\/span><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Primary sclerosing cholangitis (PSC)<\/td>\n<\/a>1<\/td>\n\u25ce<\/td>\nUnnecessary<\/td>\nHPS1972<\/td>\nHPS1973<\/td>\nHPS1974<\/td>\nHPS1975<\/td>\nHPS1976<\/td>\nHPS1977<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
3. Autoimmune hepatitis (AIH)<\/span><\/strong><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Autoimmune hepatitis (AIH)<\/td>\n1<\/td>\n\u25ce<\/td>\nUnnecessary<\/td>\nHPS1222<\/td>\nHPS1223<\/td>\nHPS1224<\/td>\nHPS1225<\/td>\nHPS1226<\/td>\nHPS1227<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
2<\/td>\n\u25ce<\/td>\nUnnecessary<\/td>\nHPS1270<\/td>\nHPS1271<\/td>\nHPS1272<\/td>\nHPS1273<\/td>\nHPS1274<\/td>\nHPS1275<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Autoimmune hepatitis (AIH), AMA positive<\/td>\n<\/a>1<\/td>\n\u25ce<\/td>\nUnnecessary<\/td>\nHPS2472<\/td>\nHPS2473<\/td>\nHPS2474<\/td>\nHPS2475<\/td>\nHPS3476<\/td>\nHPS2477<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
4. Crohn\u2019s disease<\/span><\/strong><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Crohn’s disease, ileal type<\/td>\n1<\/td>\n\u25ce<\/td>\nUnnecessary<\/td>\nHPS1508<\/td>\nHPS1509<\/td>\nHPS1510<\/td>\nHPS1511<\/td>\nHPS1512<\/td>\nHPS1513<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
2<\/td>\n\u25ce<\/td>\nUnnecessary<\/td>\nHPS2816<\/td>\nHPS2817<\/td>\nHPS2818<\/td>\nHPS2819<\/td>\nHPS2820<\/td>\nHPS2821<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Crohn’s disease, ileocolic type<\/td>\n1<\/td>\n\u25ce<\/td>\nUnnecessary<\/td>\nHPS2054<\/td>\nHPS2055<\/td>\nHPS2056<\/td>\nHPS2057<\/td>\nHPS2058<\/td>\nHPS2059<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Crohn’s disease, colic type<\/td>\n<\/a>1<\/td>\n\u25ce<\/td>\nUnnecessary<\/td>\nHPS3278<\/a><\/td>\nHPS3279<\/td>\nHPS3280<\/td>\nHPS3281<\/td>\nHPS3282<\/td>\nHPS3283<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
5. Ulcerative colitis<\/strong><\/span><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Ulcerative colitis, total colitis<\/td>\n1<\/td>\n\u25ce<\/td>\nUnnecessary<\/td>\nHPS1397<\/td>\nHPS1398<\/td>\nHPS1399<\/td>\nHPS1400<\/td>\nHPS1401<\/td>\nHPS1402<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
2<\/td>\n\u25ce<\/td>\nUnnecessary<\/td>\nHPS1430<\/td>\nHPS1431<\/td>\nHPS1432<\/td>\nHPS1433<\/td>\nHPS1434<\/td>\nHPS1435<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Ulcerative colitis, proctitis<\/td>\n<\/a>1<\/td>\n\u25ce<\/td>\nUnnecessary<\/td>\nHPS2678<\/td>\nHPS2679<\/td>\nHPS2680<\/td>\nHPS2681<\/td>\nHPS2682<\/td>\nHPS2683<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
6. Eosinophilic \uff47astro-intestinal disorde<\/strong><\/span><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Eosinophilic \uff47astro-intestinal disorder, eosinophilic gastroenteritis<\/td>\n<\/a>1<\/td>\n\u25ce<\/td>\nUnnecessary<\/td>\nHPS2268<\/td>\nHPS2269<\/td>\nHPS2270<\/td>\nHPS2271<\/td>\nHPS2272<\/td>\nHPS2273<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
7. hronic nonspecific multiple ulcers of the small intestine<\/strong><\/span><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Chronic nonspecific multiple ulcers of the small intestine<\/td>\n<\/a>1<\/td>\n\u25ce<\/td>\nUnnecessary<\/td>\nHPS2977<\/td>\nHPS2978<\/td>\nHPS2979<\/td>\nHPS2980<\/td>\nHPS2981<\/td>\nHPS2982<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
8. Hirschsprung\u2019s disease<\/strong><\/span><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Hirschsprung’s disease, total colonic aganglionosis<\/td>\n<\/a>1<\/td>\n\u25ce<\/td>\nUnnecessary<\/td>\nHPS3242<\/a><\/td>\nHPS3243<\/a> <\/td>\nHPS3244<\/a><\/td>\nHPS3245<\/td>\nHPS3246<\/td>\nHPS3247<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Diseases due to chromosomal aberrations and gene mutations<\/span><\/strong><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
1. Rubinstein-Taybi syndrom<\/strong><\/span><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Rubinstein-Taybi syndrome, mutation in CREBBP<\/td>\n<\/a>1<\/td>\n\u25ce<\/td>\nUnnecessary<\/td>\nHPS2876<\/a> <\/td>\nHPS2877<\/td>\nHPS2878<\/td>\nHPS2879<\/td>\nHPS2880<\/td>\nHPS2881<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
2. CFC syndrome<\/strong><\/span><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
CFC syndrome, mutation in BRAF<\/td>\n<\/a>1<\/td>\n\u25ce<\/td>\nUnnecessary<\/td>\nHPS3161<\/td>\nHPS3162<\/td>\nHPS3163<\/td>\nHPS3164<\/td>\nHPS3465<\/td>\nHPS3466<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
3. Pachydermoperiostosis, possible case<\/strong><\/span><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Pachydermoperiostosis, possible case<\/td>\n<\/a>1<\/td>\n\u25ce<\/td>\nUnnecessary<\/td>\nHPS3260<\/td>\nHPS3261<\/td>\nHPS3262<\/td>\nHPS3263<\/td>\nHPS3264<\/td>\nHPS3265<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
4. Williams syndrome <\/span><\/strong><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Williams syndrome<\/td>\n1<\/td>\n\u25ce<\/td>\nUnnecessary<\/td>\nHPS2550<\/td>\nHPS2551<\/td>\nHPS2552<\/td>\nHPS2553<\/td>\nHPS2554<\/td>\nHPS2555<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
<\/a>2<\/td>\n\u25ce<\/td>\nUnnecessary<\/td>\nHPS3332<\/td>\nHPS3333<\/td>\nHPS3334<\/td>\nHPS3335<\/td>\nHPS3336<\/td>\nHPS3337<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
5. ATR-X syndrome<\/span><\/strong><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
X-Linked \u03b1-Thalassemia, Mental Retardation Syndrome (ATR-X syndrome)<\/td>\n1<\/td>\n<\/td>\n<\/td>\nHPS0207*<\/a><\/td>\nHPS0208*<\/a><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
<\/a>2<\/td>\n<\/td>\n<\/td>\nHPS1007*<\/td>\nHPS1008*<\/td>\nHPS1009*<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
6. Coffin-Siris syndrome<\/strong><\/span><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Coffin-Siris syndrome, mutation in ARID1B<\/td>\n<\/a>1<\/td>\n\u25ce<\/td>\nUnnecessary<\/td>\nHPS2822<\/td>\nHPS2823<\/td>\nHPS2824<\/td>\nHPS2825<\/td>\nHPS2826<\/td>\nHPS2827<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
7. Kabuki syndrome <\/strong><\/span><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Kabuki syndrome<\/td>\n<\/a>1<\/td>\n\u25ce<\/td>\nUnnecessary<\/td>\nHPS3096<\/td>\nHPS3097<\/td>\nHPS3098<\/td>\nHPS3099<\/td>\nHPS3100<\/td>\nHPS3101<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
8. Werner syndrome<\/span><\/strong><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Werner syndrome (RCB0407 WS2TKB)<\/td>\n<\/a>1<\/td>\n<\/td>\n<\/td>\nHPS0193<\/td>\nHPS0284<\/td>\nHPS0285<\/td>\nHPS0287<\/td>\nHPS0288<\/a><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
9. Cockayne\u2019s syndrome<\/span><\/strong><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Cockayne’s syndrome (RCB0397 NCU-F10)<\/td>\n<\/a>1<\/td>\n<\/td>\n<\/td>\nHPS0083*<\/a><\/td>\nHPS0085*<\/a><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
10. Prader-Willi Syndrome<\/span><\/strong><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Prader-Willi Syndrome (RCB1560 PWS-Yamaguchi)<\/td>\n1<\/td>\n<\/td>\n<\/td>\nHPS0082*<\/a><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Prader-Willi Syndrome <\/td>\n1<\/td>\n<\/td>\n<\/td>\nHPS1787<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Prader-Willi Syndrome, abnomal methylation of Ch15<\/td>\n<\/a>1<\/td>\n\u25ce<\/td>\nUnnecessary<\/td>\nHPS2846<\/a><\/td>\nHPS2847<\/td>\nHPS2848<\/td>\nHPS2849<\/td>\nHPS2850<\/td>\nHPS2851<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
11. Sotos Syndrome<\/span><\/strong><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Sotos Syndrome, chromosome 5q partial deletion<\/td>\n1<\/td>\n\u25ce<\/td>\nUnnecessary<\/td>\nHPS1556<\/td>\nHPS1557<\/td>\nHPS1558<\/td>\nHPS1559<\/td>\nHPS1560<\/td>\nHPS1561<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
<\/a>2<\/td>\n\u25ce<\/td>\nUnnecessary<\/td>\nHPS2353<\/td>\nHPS2354<\/td>\nHPS2355<\/td>\nHPS2356<\/td>\nHPS2357<\/td>\nHPS2358<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
12. Noonan syndrome<\/span><\/strong><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Noonan syndrome<\/td>\n<\/a>1<\/td>\n<\/td>\n<\/td>\nHPS0998*<\/td>\nHPS0999*<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
13. 1p36 deletion syndrome<\/strong><\/span><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
1p36 deletion syndrome<\/td>\n<\/a>1<\/td>\n\u25ce<\/td>\nUnnecessary<\/td>\nHPS1912<\/td>\nHPS1913<\/td>\nHPS1914<\/td>\nHPS1915<\/td>\nHPS1916<\/td>\nHPS1917<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
14. 4p deletion syndrome<\/strong><\/span><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
4p deletion syndrome, deletion of 4p16.3<\/td>\n<\/a>1<\/td>\n\u25ce<\/td>\nUnnecessary<\/td>\nHPS3001<\/a> <\/td>\nHPS3002<\/a><\/td>\nHPS3003<\/a><\/td>\nHPS3004<\/td>\nHPS3005<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
15. 5p deletion syndrome<\/strong><\/span><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
5p-syndrome<\/td>\n<\/a>1<\/td>\n\u25ce<\/td>\nUnnecessary<\/td>\nHPS1685<\/td>\nHPS1686<\/td>\nHPS1687<\/td>\nHPS1688<\/td>\nHPS1689<\/td>\nHPS1690<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
2<\/td>\n\u25ce<\/td>\nUnnecessary<\/td>\nHPS2208<\/td>\nHPS2209<\/td>\nHPS2210<\/td>\nHPS2211<\/td>\nHPS2212<\/td>\nHPS2213<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
16. Smith-Magenis syndrome<\/strong><\/span><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Smith-Magenis syndrome, chromosome 17p partial deletion<\/a><\/td>\n1<\/td>\n\u25ce<\/td>\nUnnecessary<\/td>\nHPS1550<\/td>\nHPS1551<\/td>\nHPS1552<\/td>\nHPS1553<\/td>\nHPS1554<\/td>\nHPS1555<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
17. 22q11.2 deletion syndrome<\/strong><\/span><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
22q11.2 deletion syndrome<\/td>\n<\/a>1<\/td>\n\u25ce<\/td>\nUnnecessary<\/td>\nHPS1627<\/a> <\/td>\nHPS1628<\/a> <\/td>\nHPS1629<\/a> <\/td>\nHPS1630<\/td>\nHPS1631<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
<\/a>2<\/td>\n\u25ce<\/td>\nUnnecessary<\/td>\nHPS2296<\/a> <\/td>\nHPS2297<\/a> <\/td>\nHPS2298<\/a> <\/td>\nHPS2299<\/td>\nHPS2300<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
18. Epstein syndrome<\/span><\/strong><\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n
Epstein syndrome<\/td>\n1<\/td>\n\u25ce<\/td>\nUnnecessary<\/td>\nHPS0452<\/td>\nHPS0453<\/td>\nHPS0454<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/td>\nPMID: 23193063<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n","protected":false},"excerpt":{"rendered":"

\uff0a When you want to use some Disease-specific iPS cells, please e-mail to the following address. \uff0a In relation to the information that are not described below, please e-mail to the following address. Contact us :\u00a0cellips.brcriken.jp Blue letter cells are available. You obtain the information by clicking the blue letter. *iPS cells created using the Sendai virus vector are now available *Terms: In relation to all iPS cell lines, approval of institutional review board and\/or institutional ethical committee regarding the research using iPS cells is necessary. In relation to all iPS cell lines, commercial use is prohibited. In relation to the cell lines marked with \u25ce, (1) the recipient does not need to obtain an approval from the depositor, (2) there is no need of collaboration with the depositor, and (3) for-profit entities can also utilize. Update : 2020.11.27 Name of diseases Patient No. *Terms Approval Form HPS References Otorhinolaryngologic diseases 1. Branchio-oto-renal syndrome Branchio-oto-renal syndrome 1 HPS3981 HPS3982 HPS3983 Digestive system diseases 1. Primary biliary cirrhosis (PBC) Primary biliary cirrhosis (PBC) 1 \u25ce Unnecessary HPS1174 HPS1175 HPS1176 HPS1177 HPS1178 HPS1179 2 \u25ce Unnecessary HPS1234 HPS1235 HPS1236 HPS1237 HPS1238 HPS1239 3 \u25ce Unnecessary HPS1246 HPS1247 HPS1248 HPS1249 HPS1250 HPS1251 4 […]<\/p>\n","protected":false},"author":15,"featured_media":0,"parent":10124,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_seopress_titles_title":"","_seopress_titles_desc":"","_seopress_robots_index":"","_seopress_robots_follow":"","_seopress_robots_imageindex":"","_seopress_robots_snippet":"","_seopress_robots_primary_cat":"","_seopress_robots_breadcrumbs":"","_seopress_robots_freeze_modified_date":"","_seopress_robots_custom_modified_date":"","_seopress_robots_canonical":"","_seopress_social_fb_title":"","_seopress_social_fb_desc":"","_seopress_social_fb_img":"","_seopress_social_fb_img_attachment_id":0,"_seopress_social_fb_img_width":0,"_seopress_social_fb_img_height":0,"_seopress_social_twitter_title":"","_seopress_social_twitter_desc":"","_seopress_social_twitter_img":"","_seopress_social_twitter_img_attachment_id":0,"_seopress_social_twitter_img_width":0,"_seopress_social_twitter_img_height":0,"_seopress_redirections_value":"","_seopress_redirections_enabled":"","_seopress_redirections_enabled_regex":"","_seopress_redirections_logged_status":"both","_seopress_redirections_param":"","_seopress_redirections_type":301,"_seopress_analysis_target_kw":"","footnotes":"","_wp_rev_ctl_limit":""},"class_list":["post-10163","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"http:\/\/cell.brc.riken.jp\/en\/wp-json\/wp\/v2\/pages\/10163","targetHints":{"allow":["GET"]}}],"collection":[{"href":"http:\/\/cell.brc.riken.jp\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"http:\/\/cell.brc.riken.jp\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"http:\/\/cell.brc.riken.jp\/en\/wp-json\/wp\/v2\/users\/15"}],"replies":[{"embeddable":true,"href":"http:\/\/cell.brc.riken.jp\/en\/wp-json\/wp\/v2\/comments?post=10163"}],"version-history":[{"count":2,"href":"http:\/\/cell.brc.riken.jp\/en\/wp-json\/wp\/v2\/pages\/10163\/revisions"}],"predecessor-version":[{"id":10194,"href":"http:\/\/cell.brc.riken.jp\/en\/wp-json\/wp\/v2\/pages\/10163\/revisions\/10194"}],"up":[{"embeddable":true,"href":"http:\/\/cell.brc.riken.jp\/en\/wp-json\/wp\/v2\/pages\/10124"}],"wp:attachment":[{"href":"http:\/\/cell.brc.riken.jp\/en\/wp-json\/wp\/v2\/media?parent=10163"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}